Inhaled Biologics: Opportunities, Challenges, And Insights In Drug Delivery Device Development

Inhaled biologics: opportunities, challenges, and insights in drug delivery device development

Bench-to-Bedside Series: Translational Inhalation Drug Delivery – Development of Inhaled Biologics

New York Medical College

Steven Kaufman - Bespak & Aesica - The challenge of high viscosity biologics

CPHI Global Pharma Events

Advances in Medical Devices and their impact on Drug Delivery

GCP-Mindset - All About Clinical Research

Lipid-Based Drug Delivery and Oral Delivery of Biologics

ABITEC Corporation

Top Considerations for the Development of Inhaled Biologics

BioProcess International

Pulmonary Drug Delivery, Hard Capsules and Dry Powder Inhalers: Solving Development Challenges

Discovery & Development of Inhaled Biopharmaceuticals

Drug Discovery World

A View On Manufacturing Inhaled Drug Products

2nd Respiratory Drugs Summit: Formulation & Drug Delivery

Pursuing The World’s First Prescription Drug Approval of an Inhaled Cannabis Product - Erin Prosk

Medicinal Genomics

Pathways for Pulmonary Delivery

Catalent Pharma Solutions

Nanoparticle-based drug delivery in the fight against cancer

Institute for Molecular Bioscience

Translating Inhaled and Nasal Technologies for the Delivery of Biologics

BioProcess International

Fernando Diez - Sustainable Capsule based Inhalation Drug Delivery

CPHI Global Pharma Events

Vol 47: Guide to Developing Combination Products: Regulations & Challenges

The Impact of Inhalation Delay on Lung Drug Delivery

Monaghan Medical Corporation

Q&A with Dr. Ashlee Brunaugh: Designing Inhaled Drugs to Overcome Antibiotic Resistance

PhRMAFoundation

Heuer_The Latest on Asthma Medications From SABA's to Biologics and Beyond Sound 1

Terrence Shenfield

Challenges in Developing Drug-Device Combinations: A Case Study of Soft Mist Inhalers

BRASI EDUCATION